文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

死亡率差距收窄:美国退伍军人类风湿关节炎患者全国匹配队列研究中特定病因死亡率的时间趋势。

A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis.

机构信息

VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.

University of Nebraska Medical Center, Omaha.

出版信息

Arthritis Care Res (Hoboken). 2023 Aug;75(8):1648-1658. doi: 10.1002/acr.25053. Epub 2023 Jan 25.


DOI:10.1002/acr.25053
PMID:36331101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10275614/
Abstract

OBJECTIVE: To examine temporal trends in all-cause and cause-specific mortality in patients with rheumatoid arthritis (RA) in the Veterans Health Administration (VHA). METHODS: We conducted a matched cohort study in the VHA from January 1, 2000 to December 31, 2017. Incident RA patients were matched up to 1:10 on age, sex, and VHA enrollment year to non-RA patients, then followed until death or end of study period. Cause of death was obtained from the National Death Index. Multivariable Cox regression models stratified by RA diagnosis years were used to examine trends in RA-related risk of all-cause and cause-specific mortality. RESULTS: Among 29,779 incident RA patients (matched to 245,226 non-RA patients), 9,565 deaths occurred. RA patients were at increased risk of all-cause (adjusted hazard ratio [HR ] 1.23 [95% confidence interval (95% CI) 1.20-1.26]), cardiovascular (HR 1.19 [95% CI 1.14-1.23]), cancer (HR 1.19 [95% CI 1.14-1.24]), respiratory (HR 1.46 [95% CI 1.38-1.55]), and infection-related mortality (HR 1.59 [95% CI 1.41-1.80]). Interstitial lung disease was the cause of death most strongly associated with RA (HR 3.39 [95% CI 2.88-3.99]). Nearly 70% of excess deaths in RA were attributable to cardiopulmonary disease. All-cause mortality risk related to RA was lower among those diagnosed during 2012-2017 (HR 1.10 [95% CI 1.05-1.15]) compared to 2000-2005 (HR 1.31 [95% CI 1.26-1.36]), but still higher than for non-RA controls (P < 0.001). Cause-specific mortality trends were similar. CONCLUSION: Excess RA-related mortality was driven by cardiovascular, cancer, respiratory, and infectious causes, particularly cardiopulmonary diseases. Although our findings support that RA-related mortality risk is decreasing over time, a mortality gap remains for all-cause and cause-specific mortality in RA.

摘要

目的:在退伍军人健康管理局(VA)中研究类风湿关节炎(RA)患者全因和病因特异性死亡率的时间趋势。

方法:我们在 VA 中进行了一项匹配队列研究,时间范围为 2000 年 1 月 1 日至 2017 年 12 月 31 日。将新诊断为 RA 的患者与年龄、性别和 VA 登记年份相匹配的非 RA 患者按 1:10 的比例进行匹配,然后随访至死亡或研究期末。通过国家死亡索引获得死因。使用多变量 Cox 回归模型,按 RA 诊断年份分层,以研究 RA 相关全因和病因特异性死亡率的趋势。

结果:在 29779 例新发 RA 患者(与 245226 例非 RA 患者相匹配)中,有 9565 例死亡。RA 患者全因死亡率(调整后的危险比[HR]1.23[95%置信区间(95%CI)1.20-1.26])、心血管疾病(HR 1.19[95%CI 1.14-1.23])、癌症(HR 1.19[95%CI 1.14-1.24])、呼吸疾病(HR 1.46[95%CI 1.38-1.55])和感染相关死亡率(HR 1.59[95%CI 1.41-1.80])均升高。间质性肺病是与 RA 相关性死亡的最主要原因(HR 3.39[95%CI 2.88-3.99])。RA 患者中约 70%的超额死亡归因于心肺疾病。与 2000-2005 年(HR 1.31[95%CI 1.26-1.36])相比,2012-2017 年期间诊断出的 RA 患者的全因死亡率风险(HR 1.10[95%CI 1.05-1.15])较低,但仍高于非 RA 对照组(P<0.001)。病因特异性死亡率趋势相似。

结论:心血管疾病、癌症、呼吸疾病和传染病是导致 RA 相关死亡率增加的主要原因,尤其是心肺疾病。尽管我们的研究结果表明 RA 相关死亡率风险随时间降低,但 RA 的全因和病因特异性死亡率仍存在差距。

相似文献

[1]
A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis.

Arthritis Care Res (Hoboken). 2023-8

[2]
Risk of Prostate Cancer in US Veterans With Rheumatoid Arthritis.

Arthritis Care Res (Hoboken). 2023-4

[3]
Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.

Arthritis Care Res (Hoboken). 2016-1

[4]
Mortality trends in rheumatoid arthritis: the role of rheumatoid factor.

J Rheumatol. 2008-6

[5]
Cause-Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study.

Arthritis Care Res (Hoboken). 2023-4

[6]
Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals.

Arthritis Rheumatol. 2021-12

[7]
Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Ann Rheum Dis. 2017-6

[8]
Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.

Arthritis Care Res (Hoboken). 2010-3

[9]
Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.

Arthritis Care Res (Hoboken). 2017-12-6

[10]
Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink.

Rheumatology (Oxford). 2018-6-1

引用本文的文献

[1]
Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand.

Intern Med J. 2025-7

[2]
Long-term survival evaluation after transcatheter aortic valve implantation in patients with severe aortic valve stenosis: a retrospective cohort study.

Sci Rep. 2025-4-1

[3]
Lung ultrasound outperforms symptom-based screening to detect interstitial lung disease associated with rheumatoid arthritis.

RMD Open. 2025-2-26

[4]
Mortality and Predictive Factors for Death Following the Diagnosis of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Retrospective, Long-Term Follow-Up Study.

J Clin Med. 2025-2-19

[5]
Detecting respiratory impairment in newly diagnosed rheumatoid arthritis by MRC dyspnoea scale and microfibrillar-associated protein 4.

Eur Clin Respir J. 2025-1-17

[6]
Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guideline.

Curr Treatm Opt Rheumatol. 2024-12

[7]
Citrullinated and malondialdehyde-acetaldehyde-modified fibrinogen activates macrophages and promotes profibrotic responses in human lung fibroblasts.

Am J Physiol Lung Cell Mol Physiol. 2025-1-1

[8]
Rheumatoid arthritis-associated interstitial lung disease: Advancing the identification and management.

Semin Arthritis Rheum. 2025-2

[9]
Use of Upadacitinib to Treat a Severe Flare-Up of Rheumatoid Arthritis During Anti-PD-1 Immune Checkpoint Inhibitor Therapy for Stage IV Squamous Cell Carcinoma of the Lung.

J Clin Med. 2024-10-20

[10]
Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review.

Rev Colomb Reumatol. 2024-4

本文引用的文献

[1]
Long-Term Outcomes of Surgical Aortic Valve Replacement in Patients with Rheumatoid Arthritis.

J Clin Med. 2021-6-4

[2]
Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals.

Arthritis Rheumatol. 2021-12

[3]
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden.

Ann Rheum Dis. 2021-2

[4]
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.

Ann Intern Med. 2020-12-1

[5]
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.

Rheumatology (Oxford). 2021-1-5

[6]
Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study.

Rheumatology (Oxford). 2020-3-1

[7]
Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis.

Arthritis Care Res (Hoboken). 2020-10

[8]
Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy.

Clin Rheumatol. 2019-6-3

[9]
Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis.

BMC Rheumatol. 2019-2-25

[10]
Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival.

Clin Rheumatol. 2018-10-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索